Skip to Content

STO 150 (Carbidopa, Entacapone and Levodopa 37.5 mg / 200 mg / 150 mg)

Pill with imprint STO 150 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 37.5 mg / 200 mg / 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for STO 150

Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg STO 150
Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg STO 150
Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg STO 150

Carbidopa, Entacapone and Levodopa

Imprint
STO 150
Strength
37.5 mg / 200 mg / 150 mg
Color
Red
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8304

Get help with Imprint Code FAQs.

Related Images for "STO 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.